Email: k.b.rypdal@studmed.uio.no
Karoline Bjarnesdatter Rypdal was a PhD fellow at IEMR between 2017-2021, and continues her collaboration with IEMR researchers as a postdoc in the group of Ida G. Lunde at the Faculty of Medicine, University of Oslo, Campus Ahus.
Education
– MSc molecular medicine, 2015 NTNU
Awards
– Young Investigator Award, Heart Failure Association winter meeting, 2020
Academic interests
– Genetics/Genomics
– DNA/RNA high throughput sequencing
– Mouse models
– Heart failure
– Fibroblast biology
– Molecular analysis
Research area
- Cardiomyopathies
- Cell signaling
- Fibroblast signaling
- Fibrosis
- Genetic cardiology
- Heart failure
Latest publications
Rypdal KB, Olav Melleby A, Robinson EL, Li J, Palmero S, Seifert DE, Martin D, Clark C, López B, Andreassen K, Dahl CP, Sjaastad I, Tønnessen T, Stokke MK, Louch WE, González A, Heymans S, Christensen G, Apte SS, Lunde IG (2022)
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload
Commun Biol, 5 (1), 1392
PubMed 36539599 DOI 10.1038/s42003-022-04361-1
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload
Commun Biol, 5 (1), 1392
PubMed 36539599 DOI 10.1038/s42003-022-04361-1
Rypdal KB, Erusappan PM, Melleby AO, Seifert DE, Palmero S, Strand ME, Tønnessen T, Dahl CP, Almaas V, Hubmacher D, Apte SS, Christensen G, Lunde IG (2021)
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
Sci Rep, 11 (1), 19757
PubMed 34611183 DOI 10.1038/s41598-021-99032-2
The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts
Sci Rep, 11 (1), 19757
PubMed 34611183 DOI 10.1038/s41598-021-99032-2